About Cure Plus Biosciences
Cure Plus Biosciences is a Healthcare company based in India. Healthcare products and services in biologics, orthopedics, and pain management in Pune, India. The company has 1 employees. Its Indian entity Cure Plus Biosciences Private Limited reported revenue of ₹2.79 Cr. Cure Plus Biosciences offers products and services including Biologics and Orthopedic Implants. Its focus areas include Medical Devices, Orthopedics, Implants and Biologics.
Company details
Cure Plus Biosciences is recognized for its involvement in providing products that are utilized in biologics and orthopedics to enhance healing and manage chronic conditions. Products are offered to healthcare providers to support pain alleviation and mobility restoration through innovative and affordable means. The company is noted for enabling innovators via marketing strategies and supply chain management, while programs are implemented for disease management to improve patient outcomes and reduce costs associated with complications. Insights into clinical outcomes are gathered to foster technological advancements in affordability and effectiveness.
- Headquarters India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn Facebook
- Legal Name Cure Plus Biosciences Pvt. Ltd
- Date of Incorporation 30 Jun, 2020
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹2.79 Cr
FY 2024 · +67% YoY
- Net Profit₹6.8 Lakh
FY 2024 · 2% margin
- EBITDA₹21.3 Lakh
FY 2024 · 8% margin
- Employee Count1
Associated legal entities of Cure Plus Biosciences
Cure Plus Biosciences operates through Cure Plus Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cure Plus Biosciences Private Limited CIN U51909PN2020PTC191589 | Active | 30 Jun 2020 | Pune, Maharashtra | ₹2.8 Cr | 2 | View details |
Products & Services of Cure Plus Biosciences
Cure Plus Biosciences offers a comprehensive portfolio of products and services, including Biologics and Orthopedic Implants.
Biologics are used to improve the healing of fractured bones and injured muscles, tendons, and ligaments, which are derived from substances naturally found in the body.
Orthopedic implants are manufactured to replace a missing joint or bone or to support a damaged bone through surgical procedures.
Board of directors of Cure Plus Biosciences Private Limited (Cure Plus Biosciences)
Cure Plus Biosciences Private Limited is the primary company behind Cure Plus Biosciences. The board of Cure Plus Biosciences Private Limited currently have 2 directors; the longest-serving is Chetan Purushotam Wadgure, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chetan Purushotam Wadgure DIN 08776521 | Director | 30 Jun 2020 | 6 yrs 3 mo | Cure Plus Biosciences Private Limited |
| Sulbha Laxman Hingane DIN 10193204 | Director | 31 Oct 2023 | 2 yrs 11 mo | Cure Plus Biosciences Private Limited |
Financials of Cure Plus Biosciences
Figures of Cure Plus Biosciences Private Limited, the primary company behind Cure Plus Biosciences, for FY 2024. Revenue was ₹2.79 Cr (+67% year on year). Net profit was ₹6.8 Lakh (2% margin). EBITDA was ₹21.3 Lakh (8% margin). Revenue has grown at a compounded annual rate of +167% over three years.
- ₹2.79 CrRevenue · FY 2024 · +67% YoY
- ₹6.8 LakhNet profit · 2% margin
- ₹21.3 LakhEBITDA · 8% margin
- ₹1 LakhPaid-up capital
- +167%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Cure Plus Biosciences Private Limited are on its company page.
Detailed financial statements for Cure Plus Biosciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cure Plus Biosciences
Cure Plus Biosciences is headquartered in India.
Cure Plus Biosciences has 1 employees.
The primary company behind Cure Plus Biosciences, Cure Plus Biosciences Private Limited, reported revenue of ₹2.79 Cr for FY 2024, up 67% year on year.
Cure Plus Biosciences is recognized for its involvement in providing products that are utilized in biologics and orthopedics to enhance healing and manage chronic conditions. Products are offered to healthcare providers to support pain alleviation and mobility restoration through innovative and affordable means. The company is noted for enabling innovators via marketing strategies and supply chain management, while programs are implemented for disease management to improve patient outcomes and reduce costs associated with complications. Insights into clinical outcomes are gathered to foster technological advancements in affordability and effectiveness.
Cure Plus Biosciences offers Biologics and Orthopedic Implants.
Cure Plus Biosciences operates through Cure Plus Biosciences Private Limited.
The legal entities of Cure Plus Biosciences currently have 2 directors, including Sulbha Laxman Hingane, Chetan Purushotam Wadgure.